March 12, 2008 Oncolys BioPharma and Tacere Therapeutics sign strategic alliance and license agreement to develop and commercialize RNAi Hepatitis C drug
January 7, 2008 Tacere Therapeutics enters collaboration and license agreement with Pfizer to develop and commercialize RNAi Hepatitis C drug
October, 2007 | Pharmaceutical Approvals Monthly The State of RNA Interference
June 21, 2007 Oncolys BioPharma and Tacere Therapeutics form strategic alliance to develop RNAi Hepatitis C drug
October 12, 2006 Tacere Therapeutics secures financing and resumes development of RNAi Hepatitis C drug.
October 12, 2006 | Dow Jones VentureWire Hepatitis C Company Tacere Launches with Seed Round.
October 3, 2006 | The Wall Street Journal Online Nobel Discovery Already Sparked Hunt for Drugs.
